Is cardiorespiratory regulation affected by perinatal cannabinoid exposure?
- Research Opportunity
- Master of Biomedical Science
- Number of Master Places Available
- 1
| Primary Supervisor | Number | Webpage | |
|---|---|---|---|
| Dr Makhala Khammy | mmkhammy@unimelb.edu.au | Personal web page |
| Co-supervisor | Number | Webpage | |
|---|---|---|---|
| Dr Mariana Melo | |||
| Dr Aung Aung Kywe Moe |
Summary The Cardiovascular Therapeutics Unit has research interests across diverse areas of cardiovascular and autonomic pharmacology. Research areas include cannabinoid pharmacology in the vasculature and roles in the autonomic and sensory nervous systems, endothelin pharmacology in the setting of pulmonary hypertension, snake venom toxinology and vascular reactivity in hypertension.
Project Details
The Cardiovascular Therapeutics Unit has research interests across diverse areas of cardiovascular and autonomic pharmacology. Research areas include cannabinoid pharmacology in the vasculature and roles in the autonomic and sensory nervous systems, endothelin pharmacology in the setting of pulmonary hypertension, snake venom toxinology and vascular reactivity in hypertension.
Cannabis is the most widely consumed illicit drug in Australia and globally, even amongst pregnant women. As social attitudes towards cannabis use shift towards perceived harmlessness, the prevalence of cannabis use in pregnant women is expected to increase. Thus, research on the effects of cannabis exposure during pregnancy on the offspring is urgently needed.
Research Opportunities
Master of Biomedical Science
Students who are interested in joining this project will need to consider their elegibility as well as other requirements before contacting the supervisor of this research
Key Contact
For further information about this research, please contact a supervisor.
MDHS Research library
Explore by researcher, school, project or topic.